Updates on Therapies for Metastatic RCC Joseph, Richard W.; Tannir, Nizar M. Joseph, Richard W.; Tannir, Nizar M. Less Oncology Times. 38(13):6-8, July 10, 2016. Favorite PDF Permissions Free
Phase I Trial of HIF2-α inhibitor Reports No Dose-Limiting Toxicity Hocevar, Robin Hocevar, Robin Less Oncology Times. 38(13):9-10, July 10, 2016. Favorite PDF Permissions Free
Phase III Study Supports Treatment of Renal Cell Carcinoma With Cabozantinib Nalley, Catlin Nalley, Catlin Less Oncology Times. 38(13):11-12, July 10, 2016. Favorite PDF Permissions Free
Common Supplement Boosts Kidney Cancer Therapy Less Oncology Times. 38(13):12, July 10, 2016. Favorite PDF Permissions Free
Clinical Trial Rejects Combination of Sunitinib & Gemcitabine for sRCC Treatment Hocevar, Robin Hocevar, Robin Less Oncology Times. 38(13):13,16, July 10, 2016. Favorite PDF Permissions Free
Nephrectomy or Not: It May Be a Question of Patient Selection Hocevar, Robin Hocevar, Robin Less Oncology Times. 38(13):14-15, July 10, 2016. Favorite PDF Permissions Free
Cabozantinib in Patients With Previously Untreated Advanced RCC Less Oncology Times. 38(13):15, July 10, 2016. Favorite PDF Permissions Free
Study Suggests Link Between Obesity & Kidney Cancer Less Oncology Times. 38(13):16, July 10, 2016. Favorite PDF Permissions Free
